23 February 2021: Original Paper
Kidney Function After Liver Transplantation in a Single Center
Grzegorz Niewiński 1ADEFG , Wiktor Smyk 2B , Agata Graczyńska 1B , Konrad Kostrzewa 3C , Joanna Raszeja-Wyszomirska 2ADEF* , Urszula Ołdakowska-Jedynak 4DF , Jolanta Małyszko 4DF , Maciej Wójcicki 2DF , Krzysztof Zieniewicz 5DEFDOI: 10.12659/AOT.926928
Ann Transplant 2021; 26:e926928
Table 3 Factors associated with the highest SCr during the whole analyzed period.
| SCr ≥1.5 mg/dL | SCr <1.5 mg/dL | p-Value | |
|---|---|---|---|
| Age (years) | 58±15 | 48±22.75 | 0.0008 |
| Serum sodium | 138.35±5.375 | 139.3±5.9 | 0.398 |
| SCr before LT (mg/dL) | 1.08±0.36 | 0.7±0.27 | 0.0000184 |
| Colloids (mL) | 1050±600 | 925±600 | 0.0996 |
| Crystalloids (mL) | 4000±1000 | 4000±1000 | 0.28 |
| Anhepatic phase duration (minutes) | 93±45 | 90±53 | 0.22 |
| Hypotonia (MAP ≤80 mmHg) (% of patients) | 52 | 52 | 0.985 |
| Catecholamines usage during LT (n of patients) | 20 | 16 | 0.13 |
| Urine output during LT (≤100 mL/hour) (n of patients) | 34 | 40 | 0.442 |
| Tacrolimus blood through level (ng/mL) | 8.35±8.925 | 8.8±5.4 | 0.47 |
| SCr – serum creatinine; MAP – mean arterial pressure. Data presented as median±IQR. | |||